TMCI
Treace Medical Concepts, Inc.
Medical Devices · Healthcare · United States
4.43
close · 2026-10-30
value
27
cheaper than peers27
quality
7
stronger fundamentals7
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 1.40× | 72 |
| earnings yield, 2 years ago | -18.3% | 42 |
| earnings yield, 1 year ago | -20.3% | 40 |
| earnings yield, 3 years ago | -17.4% | 39 |
| price to book | 4.25× | 38 |
| cash flow yield, 3 years ago | -15.8% | 34 |
| earnings yield, latest year | -21.0% | 34 |
| cash flow yield, latest year | -10.2% | 32 |
| cash flow yield, 2 years ago | -16.0% | 32 |
| cash flow yield, 1 year ago | -16.9% | 30 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 107.8% | 29 |
| operating margin | -33.0% | 28 |
| return on equity | -72.0% | 24 |
| revenue growth | -4.2% | 14 |
4 of 4 measures available
Facts
| market cap | $288M |
| free cash flow | -$6.3M |
| employees | 450 |
| first trade | 2021-04-23 |
| next earnings | 2026-11-06 |
| fundamentals updated | 2026-09-01 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.93 | -0.90 | -0.81 | -0.77 |
| free cash flow | -$29.5M | -$48.8M | -$46.0M | -$45.5M |
| net income | -$59.0M | -$55.7M | -$49.5M | -$42.8M |
| revenue | $212.7M | $209.4M | $187.1M | $141.8M |
| unusual items | -$2.7M | $0 | $0 | -$4.5M |